Co-Authors
This is a "connection" page, showing publications co-authored by François Danion and Yvon Ruch.
Connection Strength
2.878
-
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients. Clin Microbiol Infect. 2020 Oct; 26(10):1417.e5-1417.e8.
Score: 0.894
-
Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia. Eur J Case Rep Intern Med. 2020; 7(7):001822.
Score: 0.890
-
Detection of Pneumocystis jirovecii in Patients with Severe COVID-19: Diagnostic and Therapeutic Challenges. J Fungi (Basel). 2021 Jul 22; 7(8).
Score: 0.239
-
Protracted SARS-CoV-2 pneumonia with rituximab treatment: About two cases. J Med Virol. 2021 Jul; 93(7):4141-4144.
Score: 0.234
-
The BAS2IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Oct; 7(10):ofaa405.
Score: 0.225
-
The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. Antimicrob Agents Chemother. 2020 07 22; 64(8).
Score: 0.223
-
Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021 03; 21(3):1295-1303.
Score: 0.058
-
Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Euro Surveill. 2020 12; 25(48).
Score: 0.057
-
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital. Eur J Hosp Pharm. 2021 09; 28(5):242-247.
Score: 0.057